Alaunos Therapeutics, Inc. Related Party Transaction, Amounts of Transaction
Alaunos Therapeutics, Inc. (TCRT) reported Related Party Transaction, Amounts of Transaction of $207.36 million for the 3-month period ending 2018-12-31, per its 10-K filed 2020-03-02.
Discontinued › Notes
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2020-03-02
- Alaunos Therapeutics, Inc. related party transaction, amounts of transaction for the quarter ending 2018-12-31 was $207.36M.
- Alaunos Therapeutics, Inc. related party transaction, amounts of transaction for the quarter ending 2018-09-30 was $0.00.
- Alaunos Therapeutics, Inc. related party transaction, amounts of transaction for the quarter ending 2018-06-30 was $0.00.
- Alaunos Therapeutics, Inc. related party transaction, amounts of transaction for the quarter ending 2018-03-31 was $0.00.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month | Related Party Transaction, Amounts of Transaction 9 month | Related Party Transaction, Amounts of Transaction 12 month |
|---|---|---|---|---|
| 2018-12-31 | $207.36M 10-K · filed 2020-03-02 | $207.36M derived: sum of 2 quarters · filed 2020-03-02 | $207.36M derived: sum of 3 quarters · filed 2020-03-02 | $207.36M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-09-30 | $0.00 10-K · filed 2019-03-05 | $0.00 derived: sum of 2 quarters · filed 2019-03-05 | $0.00 derived: sum of 3 quarters · filed 2019-03-05 | |
| 2018-06-30 | $0.00 10-K · filed 2019-03-05 | $0.00 derived: sum of 2 quarters · filed 2019-03-05 | ||
| 2018-03-31 | $0.00 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |